From Treating Cancer to Curing Cancer – The Promise of mRNA Vaccines in Oncology

ASCO 2022: Striving to Ensure No Patient is Left Behind

Digital Health in Japan and Korea – Where Is It Heading?

Opportunities and Challenges for Drug Makers in MDD

Rise of Innovative Medtech in APAC

AAOS 2022: The Latest Ortho Insights

Strategies to Overcome Challenges in Commercializing Treatments for Rare Diseases

Women’s Health at Home: Reflections on a Rapidly Growing Space

Building and Defending Markets; Reflections on Attending DTx and NASS Conferences

Resurgence in Drug Development for Renal Diseases

AI in Healthcare: Insights from Two Decades of FDA Approvals

Evidence Generation Strategy under Germany’s Digital Healthcare: Is More Better?

India, the Generic Manufacturing Powerhouse, Biosimilar Next?

Tencent-Backed Wedoctor Is Going Public: What Are the Next Steps for Chinese Digital Health Companies?

Hong Kong Exchange: Nurturing China’s Biotech Valley

Will Healthcare Ever Be the Same Again After COVID-19?

Overcoming Challenges to Realize the Promise of Genetic Medicine

Reflecting on the 17th Annual HBS Healthcare Conference

E-Health in Germany: Three New Laws Signify the Imminent Transformation to a Digitalised Healthcare System

New Assessment Pathway for Invasive High-Risk Medical Devices in Germany: Balancing Market Access, Evidence and Patient Benefit

Health Advances Blog

Tag: healthcare

From Treating Cancer to Curing Cancer – The Promise of mRNA Vaccines in Oncology

ASCO 2022: Striving to Ensure No Patient is Left Behind

Digital Health in Japan and Korea – Where Is It Heading?

Opportunities and Challenges for Drug Makers in MDD

Rise of Innovative Medtech in APAC

AAOS 2022: The Latest Ortho Insights

Strategies to Overcome Challenges in Commercializing Treatments for Rare Diseases

Women’s Health at Home: Reflections on a Rapidly Growing Space

Building and Defending Markets; Reflections on Attending DTx and NASS Conferences

Resurgence in Drug Development for Renal Diseases

AI in Healthcare: Insights from Two Decades of FDA Approvals

Evidence Generation Strategy under Germany’s Digital Healthcare: Is More Better?

India, the Generic Manufacturing Powerhouse, Biosimilar Next?

Tencent-Backed Wedoctor Is Going Public: What Are the Next Steps for Chinese Digital Health Companies?

Hong Kong Exchange: Nurturing China’s Biotech Valley

Will Healthcare Ever Be the Same Again After COVID-19?

Overcoming Challenges to Realize the Promise of Genetic Medicine

Reflecting on the 17th Annual HBS Healthcare Conference

E-Health in Germany: Three New Laws Signify the Imminent Transformation to a Digitalised Healthcare System

New Assessment Pathway for Invasive High-Risk Medical Devices in Germany: Balancing Market Access, Evidence and Patient Benefit